Scopus h-index:6
- Home
- Profiles
Accepting New Patients
Mount Sinai Doctors
Accepting New PatientsAnnemarie Uliasz, MD
Dermatology
Physician Office
212-298-2720
- About Me
- Clinical Focus
- Education & Certifications
- Locations
- Insurance
- Publications
- Patient Experience Rating
- Industry Relationships
About Me
Annemarie Uliasz, MD is a board-certified dermatologist at Mount Sinai Doctors.Trained in Hawaii and New York City, she is certified by the American Board of Dermatology and a member of the American Academy of Dermatology. She was awarded her medical degree from the University of Hawaii and completed her residency in Dermatology and fellowship in Dermatopharmacology at the Icahn School of Medicine at Mount Sinai. She specializes in general dermatology for patients of all ages, with a special interest in acne, psoriasis, and skin cancer.
Language
Position
Hospital Affiliations
- Mount Sinai Beth Israel
- Mount Sinai Brooklyn
- Mount Sinai Queens
- The Mount Sinai Hospital
- Mount Sinai Morningside and Mount Sinai West
About Me
Annemarie Uliasz, MD is a board-certified dermatologist at Mount Sinai Doctors.Trained in Hawaii and New York City, she is certified by the American Board of Dermatology and a member of the American Academy of Dermatology. She was awarded her medical degree from the University of Hawaii and completed her residency in Dermatology and fellowship in Dermatopharmacology at the Icahn School of Medicine at Mount Sinai. She specializes in general dermatology for patients of all ages, with a special interest in acne, psoriasis, and skin cancer.
Language
Position
Hospital Affiliations
- Mount Sinai Beth Israel
- Mount Sinai Brooklyn
- Mount Sinai Queens
- The Mount Sinai Hospital
- Mount Sinai Morningside and Mount Sinai West
About Me
Annemarie Uliasz, MD is a board-certified dermatologist at Mount Sinai Doctors.Trained in Hawaii and New York City, she is certified by the American Board of Dermatology and a member of the American Academy of Dermatology. She was awarded her medical degree from the University of Hawaii and completed her residency in Dermatology and fellowship in Dermatopharmacology at the Icahn School of Medicine at Mount Sinai. She specializes in general dermatology for patients of all ages, with a special interest in acne, psoriasis, and skin cancer.
Language
Position
Hospital Affiliations
- Mount Sinai Beth Israel
- Mount Sinai Brooklyn
- Mount Sinai Queens
- The Mount Sinai Hospital
- Mount Sinai Morningside and Mount Sinai West
Clinical Focus
Show More
- Acne
- Annual Skin Screening
- Dry / Itchy Skin
- Eczema
- Freckles
- Itch
- Nevi (Moles)
- Rash
- Rosacea
- Seborrheic Dermatitis
- Seborrheic Keratosis
- Warts
Education
MD, University of Hawaii - John A. Burns School of Medicine
Internship, Internal Medicine
St. Vincent's Hospital & Medical Center
Residency, Dermatology
The Mount Sinai Hospital
Fellowship, Dermatopharmacology
The Mount Sinai Hospital
Certifications
American Board of Dermatology
Locations
Insurance Information
Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information.
- Physician Office255 Greenwich Street, Suite 510, New York, NY, 10007
- 1199 SEIU
- AETNA - Commercial
- AETNA - Medicare
- CIGNA Healthcare
- Centivo
- EmblemHealth - GHI-PPO
- EmblemHealth - HIP
- EmblemHealth - HIP-Medicare
- Empire Blue Cross Blue Shield - Commercial/Exchange
- Empire Blue Cross Blue Shield - Medicare
- Horizon NJ
- Magnacare-Health Care
- Medicare
- Multiplan PHCS
- Oxford - Freedom & Liberty
- United Health Care - Commercial
- United Health Care - Empire Plan
- United Health Care - Oxford Care
- United Health Care - Top Tier
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Publications
Article:9
Chapter:3
Recent Artifacts
- Topical immune response modifiers: Adjuvants
- Bites and stings
- Buka's emergencies in dermatology
- Evaluation of sensory irritation caused by topical medications using a novel technique
- Placebo-controlled, double-blind, randomized pilot study of imiquimod 5% cream applied once per week for 6 months for the treatment of actinic keratoses
- Cutaneous toxoplasmosis histologically mimicking graft-versus-host disease
- A new standardized method of evaluating cutaneous irritation from topical medications
- A single-center, double-blind, randomized trial of the atrophogenic effects of fluocinonide cream 0.1% versus clobetasol propionate cream 0.05% in participants with corticosteroid-responsive dermatoses
- Cutaneous manifestations of cardiovascular diseases
- Topical immune response modifiers: Adjuvants
Patient Experience Rating
The Patient Experience Star Rating reflects our patients’ perception of how well their Mount Sinai provider communicated with them during an office visit. The Star Rating is based on patient responses to three questions on a patient experience survey, a standardized questionnaire sent to verified patients and distributed by a third party vendor, Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score.
Care Provider’s Explanation
4.9 out of 5
Care Provider’s Concern
4.8 out of 5
Likelihood to Recommend Care Provider
4.7 out of 5
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Uliasz did not report having any of the following types of financial relationships with industry during 2022 and/or 2023: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.